Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Althea Technologies, Inc.

http://www.altheatech.com/

Latest From Althea Technologies, Inc.

Seventeen And Counting – Bumper Crop Of New EU Filings

Orphan drugs and COVID-19 products are among the latest filings under review by the European Medicines Agency for potential pan-EU approval.

Europe Drug Review

China First Domestic COVID-19 Antibody Therapy Moves Towards Green Light

Brii’s antibody combo therapy nears approval in China, based on data from a late-stage study conducted outside the country.

China Coronavirus COVID-19

Deal Watch: Sanofi To Tap Owkin’s AI, Machine Learning In Oncology

French pharma makes $180m equity investment in Owkin under collaboration targeting four cancer types. Pyramid gets global license to MPS1 precision cancer candidate from Voronoi.

Deal Watch Business Strategies

Lilly Pulls COVID-19 Antibody Treatment From EU Review

While Lilly's antibody combination of etesevimab and bamlanivimab is still going strong in the US, the company has lost out to Roche's Ronapreve in the EU.

Europe United States
See All

Company Information

  • Other Names / Subsidiaries
    • Altus Pharmaceuticals Inc.
UsernamePublicRestriction

Register